Mid-Atlantic BioTherapeutics Inc is a clinical-stage biotechnology company focused on developing advanced immunotherapies and treatments for central nervous system (CNS) disorders. The company leverages innovative scientific approaches to address unmet medical needs in these areas, aiming to improve patient outcomes through cutting-edge therapeutic solutions.
Leadership & Board
Current Number of Employees4
Current LinkedIn Followers695
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$5M
Total Amount Raised$5M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Mid-Atlantic BioTherapeutics Inc had 4 employees as of April 13, 2026. The number of employees increased by 0 (0.00%) week-over-week.
4Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Mid-Atlantic BioTherapeutics Inc had 695 followers as of April 13, 2026. The number of followers increased by 1 (0.14%) week-over-week.
695Latest Followers Count
1(0.14%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.